These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38824386)

  • 21. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C; Zhang L; Hao X; Tang M; Zhou B; Hou J
    Curr Oncol; 2022 Dec; 30(1):430-448. PubMed ID: 36661684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
    Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
    Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma.
    Wang D; Zhang L; Zhang Y; Zhang Y; Xu S
    Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
    Zhao X; Bai Z; Li C; Sheng C; Li H
    Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma.
    Li R; Jin C; Zhao W; Liang R; Xiong H
    BMC Gastroenterol; 2022 Nov; 22(1):450. PubMed ID: 36344926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma.
    Shi M; Zhang XY; Yu H; Xiang SH; Xu L; Wei J; Wu Q; Jia R; Wang YG; Lu XJ
    Oncotarget; 2017 Jul; 8(27):44195-44202. PubMed ID: 28496001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis.
    Lu S; Liu X; Wu C; Zhang J; Stalin A; Huang Z; Tan Y; Wu Z; You L; Ye P; Fu C; Zhang X; Wu J
    Medicine (Baltimore); 2023 Jul; 102(29):e33990. PubMed ID: 37478241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma.
    Wu G; Yang Y; Ye R; Yue H; Zhang H; Huang T; Liu M; Zheng Y; Wang Y; Zhou Y; Guo Q
    BMC Cancer; 2022 Oct; 22(1):1036. PubMed ID: 36195857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
    Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
    Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
    Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
    Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs.
    Wu T; Li N; Luo F; Chen Z; Ma L; Hu T; Hong G; Li H
    BMC Bioinformatics; 2023 Apr; 24(1):176. PubMed ID: 37120506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma.
    Qiu H; Jiang B; Chen Y; Lin Z; Zheng W; Cao X
    J Appl Genet; 2024 May; 65(2):355-366. PubMed ID: 38347289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J; Pu J; Yao T; Lu X; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.